IDiyas

For the Inventor, By the Inventor

Hino, Japan

Kiyoshi Bannai

USPTO Granted Patents = 11

Average Co-Inventor Count = 5.9

ph-index = 4

Forward Citations = 33(Granted Patents)


Company Filing History:

goldMedal11 out of 1,586 
 
Teijin Limited
 patents

Years Active: 1980-1994

Loading Chart...
11 patents (USPTO):Explore Patents
1. 5364883 - Isocarbocyclins for the treatment of liver and kidney diseases (1994-11-15),
2. 5283349 - 2,6,7-trisubstituted-3-methylenebicyclo(3.3.0)-octanes, and process for (1994-02-01),
3. 5175338 - Isocarbacyclin derivatives and their pharmaceutically acceptable salts (1992-12-29),
4. 5159102 - 7-thiaprostaglandins E, and process for producing same (1992-10-27),
5. 4788319 - Novel isocarbacyclins and processes for production thereof (1988-11-29),
6. 4472428 - Halogenated prostacyclins pharmaceutical use thereof and hydroxy (1984-09-18),
7. 4466980 - Thiaprostaglandin E.sub.1 derivatives, process for production thereof, (1984-08-21),
8. 4421914 - Thiazolo[3,2-a]pyrimidines, derivatives thereof, processes for (1983-12-20),
9. 4383996 - Derivative of thiazolo[3,2-a]pyrimidine and a process for the (1983-05-17),
10. 4237125 - 1.alpha.-Hydroxy-24-dehydrovitamin .sub.3 pharmaceutical compositions (1980-12-02),
11. 4199577 - Novel 1.alpha.-hydroxy-24-oxovitamin D.sub.3, its preparing process and (1980-04-22),

Title: Kiyoshi Bannai: Innovator in Pharmaceutical Chemistry

Introduction

Kiyoshi Bannai is a prominent inventor based in Hino, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating various diseases. With a total of 11 patents to his name, Bannai's work has had a substantial impact on medical science.

Latest Patents

Bannai's latest patents include innovative compounds such as isocarbocyclins for the treatment of liver and kidney diseases. The compound 16(S)-Isocarbacyclins has been identified as useful in addressing these health issues. Additionally, he has developed a 2,6,7-trisubstituted-3-methylenebicyclo(3.3.0)-octane, which serves as a key intermediate for the preparation of isocarbacyclins. These compounds are valuable as medicines for the circulatory system, functioning as antithrombotic, antilipidemic, hypotensive, and antiarterosclerotic agents.

Career Highlights

Bannai is currently associated with Teijin Limited, where he continues to advance his research and development efforts. His work has been recognized within the industry, and he has established himself as a leading figure in pharmaceutical innovation.

Collaborations

Throughout his career, Bannai has collaborated with notable colleagues such as Toshio Tanaka and Seizi Kurozumi. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Kiyoshi Bannai's contributions to pharmaceutical chemistry exemplify the importance of innovation in medicine. His patents and ongoing research continue to pave the way for new treatments that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…